Switch to:

Orexigen Therapeutics Inc (OREX)Ownership Data

Short Interest History (%)

This is the historical short interest of Orexigen Therapeutics Inc, as measured by the Short Percentage Of Float.

Date Short Interest
January 30, 201541.13
January 15, 201540.18
December 31, 201438.94
December 15, 201439.88
November 28, 201439.93
November 14, 201443.36
October 31, 201444.35
October 15, 201441.25
September 30, 201440.06
September 15, 201434.46
August 29, 201428.79
August 15, 201426.57
July 31, 201426.69
July 15, 201425.33
June 30, 201424.21
June 13, 201425.74
May 30, 201422.95
May 15, 201422.36
April 30, 201421.8
April 15, 201420.04
March 31, 201418.92
March 14, 201418.41
February 28, 201417.98
February 14, 201417.68
January 31, 201416.38
January 15, 201414.9
December 31, 201313.33
December 13, 201314.08
November 29, 201310.17
November 15, 20139.34
October 31, 20138.2
October 15, 20138.86
September 30, 20138.59
September 13, 20138.25
August 30, 20138.53
August 15, 20138.28
July 31, 20137.9
July 15, 20138.53
June 28, 20139.08
June 14, 20138.45
May 31, 20138.49
May 15, 20139.42
April 30, 20139.86
April 15, 20139.66
March 28, 201313.76
March 15, 201311.29
February 28, 201314.59
February 15, 201314.99
January 31, 201315.66
January 15, 201315.54
December 31, 201216.2
December 14, 201215.76
November 30, 201215.56
November 15, 201213.69
October 31, 201213.51
October 15, 201214.15
September 28, 201213.56
September 14, 201211.9
August 31, 201210.03
August 15, 20129.9
July 31, 201210.63
July 13, 201210.05
June 29, 20127.68
June 15, 20127.33
May 31, 20127.65
May 15, 20126.87
April 30, 20126.64
April 13, 20127.36
March 30, 201212.11
March 15, 201215.85
February 29, 201215.82
February 15, 20129.37
January 31, 201210.09
January 13, 201210.19
December 30, 201110.63
December 15, 201111.6
November 30, 201112.36
November 15, 201112.94
October 31, 201111.12
October 14, 201112.04
September 30, 201112.3
September 15, 201111.66
August 31, 201111.68
August 15, 201110.55
July 29, 201111.3
July 15, 201111.96
June 30, 201113.1
June 15, 201114.2
May 31, 201116.38
May 13, 201117.91
April 29, 201118.61
April 15, 201120.36
March 31, 201117.58
March 15, 201135.56
February 28, 201140.11
February 15, 201147.9
January 31, 201123.91
January 14, 201120.57
December 31, 201026.36
December 15, 201027.61
November 30, 201035.71
November 15, 201034.26
October 29, 201032.23
October 15, 201032.97
September 30, 201034.44
September 15, 201028.92
August 31, 201028.19
August 13, 201028.26
July 30, 201024.23
July 15, 201022.47
June 30, 201019.19
June 15, 201020.11
May 28, 201020.03
May 14, 201022.6
April 30, 201020.5
April 15, 201017.14
March 31, 201014.25
March 15, 20107.48
February 26, 20107.72
February 12, 20107.7
January 29, 20107.53
January 15, 20107.53
December 31, 20097.88
December 15, 20097.96
November 30, 20097.41
November 13, 20096.43
October 30, 20096.1
October 15, 20095.69
September 30, 20095.71
September 15, 20095.56
August 31, 20094.75
August 14, 20094.77
July 31, 20096.4
July 15, 20094.8
June 30, 20094.08
June 15, 20093.05
May 29, 20093.08
May 15, 20092.59
April 30, 20092.67
April 15, 20092.92
March 31, 20093.4
March 13, 20093.76
February 27, 20094.19
February 13, 20095.25
January 30, 20095.56
January 15, 20096.68
December 31, 20084.39
December 15, 20084.83
November 28, 20084.66
November 14, 20084.91
October 31, 20085.19
October 15, 20086.21
September 30, 20086.72
September 15, 20086.62
August 29, 20086.47
August 15, 20086.49
July 31, 20086.99
July 15, 20087.64
June 30, 20085.13
June 13, 20084.92
May 30, 20084.47
May 15, 20084.03
April 30, 20083.86
April 15, 20084.05
March 31, 20084.55
March 14, 20084.49
February 29, 20084.88
February 15, 20087.24
January 31, 20086.74
January 15, 20087.84
December 31, 20075.94
December 11, 20075.38
November 27, 20075.4
November 9, 20074.24
October 26, 20074.47
October 10, 20074.43
September 25, 20073.43
September 11, 20072.92
August 10, 20072.8
July 10, 20073.02
June 12, 20070.82
May 10, 20070.46

Institutional Ownership History (%)

This the Institutional Ownership History of Orexigen Therapeutics IncPeter Lynch prefers to buy companies with low institutional ownership.

Date Institutional Ownership
January 31, 201583
December 31, 201483
November 30, 201483
October 31, 201483
September 30, 201478
August 31, 201478
July 31, 201478
June 30, 201482
May 31, 201483
April 30, 201486
March 31, 201479
February 28, 201487
January 31, 201486
December 31, 201379
November 30, 201380
October 31, 201380
September 30, 201376
August 31, 201380
July 31, 201381
June 30, 201381
May 31, 201379
April 30, 201385
March 31, 201328
December 31, 201292
November 30, 201283
October 31, 201295
September 30, 201268
August 31, 201270
July 31, 201273
June 30, 201276
May 31, 201270
April 30, 201270
March 31, 201259
February 29, 201266
January 31, 201293
December 31, 201177
November 30, 201177
October 31, 201177
September 30, 201148
August 31, 201148
July 31, 201142
June 30, 201141
May 31, 201148
April 30, 201155
March 31, 201156
February 28, 201151
January 31, 201156
December 31, 201056
November 30, 201049
October 31, 201041
September 30, 201042
August 31, 201043
July 31, 201047
June 30, 201048
May 31, 201049
April 30, 201047
March 31, 201055
February 28, 201053
January 31, 201054
December 31, 200954
November 30, 200954
October 31, 200938
September 30, 200927
August 31, 200928
July 31, 200940
June 30, 200940
May 31, 200940
April 30, 200946
March 31, 200943
February 28, 200942
January 31, 200947
December 31, 200851
November 30, 200850
October 31, 200851
September 30, 200851
August 31, 200851
July 31, 200851
June 30, 200851
May 31, 200851
April 30, 200851
March 31, 200848
February 29, 200848
January 31, 200848

Insider ownership (%)

This is the historical insider ownership of Orexigen Therapeutics Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Date Insider Ownership
March 31, 20141
February 28, 20141
January 31, 20141
December 31, 20131
November 30, 20131
October 31, 20131
September 30, 20131
August 31, 20131
July 31, 20131
June 30, 20131
May 31, 20131
April 30, 20131
March 31, 20131
January 31, 20131
November 30, 20121
October 31, 20121
September 30, 20121
August 31, 20121
July 31, 20121
June 30, 20121
May 31, 20121
April 30, 20121
March 31, 20121
February 29, 20121
January 31, 20121
December 31, 20111
November 30, 20111
October 31, 20111
September 30, 20111
August 31, 20111
July 31, 20111
June 30, 20111
May 31, 20111
April 30, 20111
March 31, 20111
February 28, 20111
January 31, 20111
December 31, 20101
November 30, 20101
October 31, 20101
September 30, 20101
August 31, 20101
July 31, 20101
June 30, 20101
May 31, 20101
April 30, 20101
March 31, 20101
February 28, 20101
January 31, 20101
December 31, 20091
November 30, 20091
October 31, 20091
September 30, 20091
August 31, 20091
July 31, 20091
June 30, 20091
May 31, 20091
April 30, 20091
March 31, 20091
February 28, 20091
January 31, 20091
December 31, 20081
November 30, 20081
October 31, 20081
September 30, 20081
August 31, 20081
July 31, 20081
June 30, 20081
May 31, 20081
April 30, 20083
March 31, 20083
February 29, 20085
January 31, 20085
December 31, 20075
November 30, 20076
October 31, 20076
September 30, 20076
August 31, 20076
July 31, 20076
June 30, 20076
May 31, 20076
April 30, 20076
March 31, 20077

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Mr. Moshe Arkin4,037,7663.28%2010-07-12
Dr. Michael A. Cowley,PhDN/A141,3440.11%2008-08-28
Michael A. NarachiPresident and CEO58,026less than 0.1%2014-09-15
Mr. Louis C. BockDirector27,677less than 0.1%2014-11-18
Joseph A. LacobN/A26,373less than 0.1%2007-05-01
Dr. Dennis D. Kim, M.D.N/A25,200less than 0.1%2009-03-24
Brian H. DoveyN/A20,128less than 0.1%2007-11-27
James C. Blair,PhD10% Owner19,373less than 0.1%2007-11-27
More Robert JN/A16,606less than 0.1%2007-11-27
Dr. Jesse I. Treu,PhD10% Owner15,096less than 0.1%2007-11-27

Top Fund Holders

HolderSharesReport Date% of Shares
Outstanding
% of Total
Assets Managed
Market Value
Fidelity Management and Research Company11,835,2112014-12-319.610.0071,721,379
Fidelity® Select Biotechnology Portfolio9,154,0092014-12-317.430.5155,473,295
T. Rowe Price Associates, Inc.6,665,2002014-12-315.410.0140,391,000
Samlyn Capital, LLC5,690,7222014-12-314.620.6034,486,000
Capital Research Global Investors5,605,6002014-12-314.550.0133,969,936
T. Rowe Price Health Sciences Fund5,287,0002014-12-314.290.2732,039,220
BlackRock Fund Advisors4,867,0022014-12-313.950.0129,494,000
State Street Corp4,729,3452014-12-313.840.0028,660,000
Foresite Capital Management II LLC4,017,6662014-12-313.2616.6724,347,000
SPDR® S&P Biotech ETF3,747,3722015-02-263.401.0621,997,074

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK